This study aimed to explore the feasibility of amide proton transfer weighted (APTw) imaging in discriminating fat-poor angiomyolipoma (AML) from clear cell renal cell carcinoma (ccRCC). 19 ccRCC patients and 9 fat-poor AML patients were recruited for APTw imaging. ccRCC group showed significantly higher MTRasym compared to fat-poor AML group (P < 0.05). High AUC of 0.827 in ROC analysis validated the efficacy of APTw imaging in differentiating fat-poor AML from ccRCC. With these findings, APTw imaging may be considered an effective method providing added clinical value in differentiating fat-poor AML from ccRCC.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords